PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 7, 2026Journal of Clinical Hypertension0 citationsOpen Access

Reversible Neurological Manifestations Preceding Biochemical Deterioration in Postpartum HELLP Syndrome—A Case Report and Literature Review

View Full Paper
DCDario ColacurciSGStefano Raffaele GiannubiloLSLaura Sarno

Key Points

  • This case report aims to highlight the occurrence of neurological symptoms before the biochemical diagnosis of HELLP syndrome.
  • Reported a postpartum case of PRES in a 22-year-old primigravida admitted for pregnancy complications.
  • Utilized brain magnetic resonance imaging to identify neurological changes and monitored biochemical markers over three days.
  • Implemented treatment with magnesium sulfate, antihypertensive therapy, corticosteroids, and plasmapheresis.
  • Neurological symptoms were observed on postpartum day 1, including headache and seizures.
  • Laboratory confirmation of HELLP syndrome occurred by postpartum day 3 with severe thrombocytopenia and elevated transaminases.
  • Achieved complete clinical and radiological recovery through multidisciplinary management.

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a rare but severe neurological complication associated with hypertensive disorders of pregnancy and HELLP syndrome. We report a postpartum case in which neurological manifestations preceded the full biochemical expression of HELLP syndrome. A 22-year-old primigravida was admitted at 36 + 0 weeks for premature rupture of membranes and fetal growth restriction, presenting with mild thrombocytopenia and elevated lactate dehydrogenase but normal liver enzymes. On postpartum day 1, she developed headache, visual disturbances, hypertensive crisis, and a generalized tonic-clonic seizure. Brain magnetic resonance imaging revealed bilateral cortical-subcortical T2/FLAIR hyperintensities consistent with PRES. At that time, laboratory findings were not yet diagnostic of HELLP syndrome; however, by postpartum day 3, severe thrombocytopenia and elevated transaminases confirmed the diagnosis. The patient was treated with magnesium sulfate, antihypertensive therapy, corticosteroids, and plasmapheresis, achieving complete clinical and radiological recovery. A narrative review of the literature indicated that neurological manifestations typically occur within 48 h postpartum. This case highlights that PRES may precede the full laboratory expression of HELLP syndrome and underscores the importance of early recognition, prompt neuroimaging, and multidisciplinary management to ensure favorable maternal outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Colacurci et al. (2026) studied this question.

synapsesocial.com/papers/69fbe357164b5133a91a2a63https://doi.org/10.1111/jch.70267
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reversible posterior leukoencephalopathy associated with postpartum HELLP syndrome2005 · 21 citations
  2. 2Síndrome de leucoencefalopatía posterior reversible: serie de casos y revisión de la literatura2018 · 7 citations
  3. 3ACOG2019 · 75 citations
  4. 4The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention2019 · 1,236 citations
  5. 5Preeclampsia-Eclampsia: Clinical and Neuroradiographic Correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy2000 · 395 citations